Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Equity Average (2016 - 2025)

Historic Equity Average for Lemaitre Vascular (LMAT) over the last 15 years, with Q3 2025 value amounting to $370.8 million.

  • Lemaitre Vascular's Equity Average rose 1398.74% to $370.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $370.8 million, marking a year-over-year increase of 1398.74%. This contributed to the annual value of $317.6 million for FY2024, which is 1220.44% up from last year.
  • Latest data reveals that Lemaitre Vascular reported Equity Average of $370.8 million as of Q3 2025, which was up 1398.74% from $355.1 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Equity Average high stood at $370.8 million for Q3 2025, and its period low was $175.0 million during Q1 2021.
  • Over the past 5 years, Lemaitre Vascular's median Equity Average value was $279.0 million (recorded in 2023), while the average stood at $281.0 million.
  • Per our database at Business Quant, Lemaitre Vascular's Equity Average surged by 5085.94% in 2021 and then surged by 521.64% in 2022.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Equity Average stood at $251.6 million in 2021, then increased by 5.22% to $264.7 million in 2022, then grew by 10.78% to $293.3 million in 2023, then rose by 13.95% to $334.2 million in 2024, then grew by 10.96% to $370.8 million in 2025.
  • Its last three reported values are $370.8 million in Q3 2025, $355.1 million for Q2 2025, and $342.4 million during Q1 2025.